146 related articles for article (PubMed ID: 20598285)
21. [Thrombophilia, preeclampsia and other pregnancy complications].
Vucić N; Frleta M; Petrović D; Ostojić V
Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
[TBL] [Abstract][Full Text] [Related]
22. Does anticoagulant therapy improve pregnancy outcome equally, regardless of specific thrombophilia type?
Kovac M; Mikovic Z; Mitic G; Djordjevic V; Mandic V; Rakicevic L; Radojkovic D
Clin Appl Thromb Hemost; 2014 Mar; 20(2):184-9. PubMed ID: 23262970
[TBL] [Abstract][Full Text] [Related]
23. Ante- and postpartum redox status of blood in women with inherited thrombophilia treated with heparin.
Pristov JB; Maglić D; Opačić M; Mandić V; Miković Z; Spasić M; Spasojević I
Thromb Res; 2012 Nov; 130(5):826-9. PubMed ID: 22981678
[No Abstract] [Full Text] [Related]
24. Monitoring of low molecular weight heparin in pregnancy.
Shiach CR
Hematology; 2003 Feb; 8(1):47-52. PubMed ID: 12623427
[No Abstract] [Full Text] [Related]
25. Evaluation of an optimal dose of low-molecular-weight heparin for thromboprophylaxis in pregnant women at risk of thrombosis using coagulation activation markers.
Bombeli T; Raddatz Mueller P; Fehr J
Haemostasis; 2001; 31(2):90-8. PubMed ID: 11684864
[TBL] [Abstract][Full Text] [Related]
26. Thrombophilia and anticoagulation in pregnancy: indications, risks and management.
Montavon C; Hoesli I; Holzgreve W; Tsakiris DA
J Matern Fetal Neonatal Med; 2008 Oct; 21(10):685-96. PubMed ID: 19012185
[TBL] [Abstract][Full Text] [Related]
27. [Hypercoagulability during pregnancy: evidences for a thrombophilic state].
Maiello M; Torella M; Caserta L; Caserta R; Sessa M; Tagliaferri A; Bernacchi M; Napolitano M; Nappo C; De Lucia D; Panariello S
Minerva Ginecol; 2006 Oct; 58(5):417-22. PubMed ID: 17006429
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of the long-term administration of low-molecular-weight heparins in pregnancy.
Santoro R; Iannaccaro P; Prejanò S; Muleo G
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):240-3. PubMed ID: 19357505
[TBL] [Abstract][Full Text] [Related]
29. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
Bremme K; Lind H; Blombäck M
Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
[TBL] [Abstract][Full Text] [Related]
30. Management of thrombophiliac problems during pregnancy.
Asghar F; Zaire M; Dwyer MO; Bhuinneain MN
Ir Med J; 2007 Jun; 100(6):507-9. PubMed ID: 17668688
[No Abstract] [Full Text] [Related]
31. The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT.
Cimenti C; Koestenberger M; Leschnik B; Haidl H; Muntean W
Thromb Res; 2007; 119(3):361-7. PubMed ID: 16712904
[TBL] [Abstract][Full Text] [Related]
32. Calibrated automated thrombin generation in normal uncomplicated pregnancy.
Rosenkranz A; Hiden M; Leschnik B; Weiss EC; Schlembach D; Lang U; Gallistl S; Muntean W
Thromb Haemost; 2008 Feb; 99(2):331-7. PubMed ID: 18278182
[TBL] [Abstract][Full Text] [Related]
33. Thrombin generation assay identifies individual variability in responses to low molecular weight heparin in pregnancy: implications for anticoagulant monitoring.
Chowdary P; Adamidou D; Riddell A; Aghighi S; Griffioen A; Priest P; Moghadam L; Kelaher N; Huq FY; Kadir RA; Tuddenham EG; Gatt A
Br J Haematol; 2015 Mar; 168(5):719-27. PubMed ID: 25351814
[TBL] [Abstract][Full Text] [Related]
34. The use of unfractionated heparin and low molecular weight heparins in pregnancy.
Casele HL
Clin Obstet Gynecol; 2006 Dec; 49(4):895-905. PubMed ID: 17082684
[TBL] [Abstract][Full Text] [Related]
35. Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden.
Lincz LF; Lonergan A; Scorgie FE; Rowlings P; Gibson R; Lawrie A; Seldon M
Pathophysiol Haemost Thromb; 2006; 35(6):435-9. PubMed ID: 17565236
[TBL] [Abstract][Full Text] [Related]
36. Low molecular weight heparin as thromboprophylaxis in familial thrombophilia during the whole period of pregnancy.
Boda Z; Laszlo P; Rejtõ L; Tornai I; Pfliegler G; Blaskó G; Rak K
Thromb Haemost; 1996 Jul; 76(1):128. PubMed ID: 8819268
[No Abstract] [Full Text] [Related]
37. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
[TBL] [Abstract][Full Text] [Related]
38. Thrombophilia and the obstetric patient.
Cleary-Goldman J; Bettes B; Robinson JN; Norwitz E; Schulkin J
Obstet Gynecol; 2007 Sep; 110(3):669-74. PubMed ID: 17766616
[TBL] [Abstract][Full Text] [Related]
39. Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial.
Qublan H; Amarin Z; Dabbas M; Farraj AE; Beni-Merei Z; Al-Akash H; Bdoor AN; Nawasreh M; Malkawi S; Diab F; Al-Ahmad N; Balawneh M; Abu-Salim A
Hum Fertil (Camb); 2008 Dec; 11(4):246-53. PubMed ID: 19085261
[TBL] [Abstract][Full Text] [Related]
40. Prevention and management of venous thromboembolism in pregnancy.
James AH
Am J Med; 2007 Oct; 120(10 Suppl 2):S26-34. PubMed ID: 17916457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
